BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1366 related articles for article (PubMed ID: 25029335)

  • 1. Activated STING in a vascular and pulmonary syndrome.
    Liu Y; Jesus AA; Marrero B; Yang D; Ramsey SE; Sanchez GAM; Tenbrock K; Wittkowski H; Jones OY; Kuehn HS; Lee CR; DiMattia MA; Cowen EW; Gonzalez B; Palmer I; DiGiovanna JJ; Biancotto A; Kim H; Tsai WL; Trier AM; Huang Y; Stone DL; Hill S; Kim HJ; St Hilaire C; Gurprasad S; Plass N; Chapelle D; Horkayne-Szakaly I; Foell D; Barysenka A; Candotti F; Holland SM; Hughes JD; Mehmet H; Issekutz AC; Raffeld M; McElwee J; Fontana JR; Minniti CP; Moir S; Kastner DL; Gadina M; Steven AC; Wingfield PT; Brooks SR; Rosenzweig SD; Fleisher TA; Deng Z; Boehm M; Paller AS; Goldbach-Mansky R
    N Engl J Med; 2014 Aug; 371(6):507-518. PubMed ID: 25029335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.
    Melki I; Rose Y; Uggenti C; Van Eyck L; Frémond ML; Kitabayashi N; Rice GI; Jenkinson EM; Boulai A; Jeremiah N; Gattorno M; Volpi S; Sacco O; Terheggen-Lagro SWJ; Tiddens HAWM; Meyts I; Morren MA; De Haes P; Wouters C; Legius E; Corveleyn A; Rieux-Laucat F; Bodemer C; Callebaut I; Rodero MP; Crow YJ
    J Allergy Clin Immunol; 2017 Aug; 140(2):543-552.e5. PubMed ID: 28087229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief Report: Blockade of TANK-Binding Kinase 1/IKKɛ Inhibits Mutant Stimulator of Interferon Genes (STING)-Mediated Inflammatory Responses in Human Peripheral Blood Mononuclear Cells.
    Frémond ML; Uggenti C; Van Eyck L; Melki I; Bondet V; Kitabayashi N; Hertel C; Hayday A; Neven B; Rose Y; Duffy D; Crow YJ; Rodero MP
    Arthritis Rheumatol; 2017 Jul; 69(7):1495-1501. PubMed ID: 28426911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Early-Onset Combined Immunodeficiency due to Heterozygous Gain-of-Function Mutations in STAT1.
    Baris S; Alroqi F; Kiykim A; Karakoc-Aydiner E; Ogulur I; Ozen A; Charbonnier LM; Bakır M; Boztug K; Chatila TA; Barlan IB
    J Clin Immunol; 2016 Oct; 36(7):641-8. PubMed ID: 27379765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STING-associated vasculopathy develops independently of IRF3 in mice.
    Warner JD; Irizarry-Caro RA; Bennion BG; Ai TL; Smith AM; Miner CA; Sakai T; Gonugunta VK; Wu J; Platt DJ; Yan N; Miner JJ
    J Exp Med; 2017 Nov; 214(11):3279-3292. PubMed ID: 28951494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel TMEM173 Mutation and the Role of Disease Modifying Alleles.
    Keskitalo S; Haapaniemi E; Einarsdottir E; Rajamäki K; Heikkilä H; Ilander M; Pöyhönen M; Morgunova E; Hokynar K; Lagström S; Kivirikko S; Mustjoki S; Eklund K; Saarela J; Kere J; Seppänen MRJ; Ranki A; Hannula-Jouppi K; Varjosalo M
    Front Immunol; 2019; 10():2770. PubMed ID: 31866997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI).
    David C; Frémond ML
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Novel SAVI-Causing Variants in
    Lin B; Torreggiani S; Kahle D; Rumsey DG; Wright BL; Montes-Cano MA; Silveira LF; Alehashemi S; Mitchell J; Aue AG; Ji Z; Jin T; de Jesus AA; Goldbach-Mansky R
    Front Immunol; 2021; 12():636225. PubMed ID: 33833757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype.
    Clarke SLN; Robertson L; Rice GI; Seabra L; Hilliard TN; Crow YJ; Ramanan AV
    Pediatr Rheumatol Online J; 2020 May; 18(1):37. PubMed ID: 32398023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioresistant cells initiate lymphocyte-dependent lung inflammation and IFNγ-dependent mortality in STING gain-of-function mice.
    Gao KM; Motwani M; Tedder T; Marshak-Rothstein A; Fitzgerald KA
    Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2202327119. PubMed ID: 35696583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases.
    Wan R; Fänder J; Zakaraia I; Lee-Kirsch MA; Wolf C; Lucas N; Olfe LI; Hendrich C; Jonigk D; Holzinger D; Steindor M; Schmidt G; Davenport C; Klemann C; Schwerk N; Griese M; Schlegelberger B; Stehling F; Happle C; Auber B; Steinemann D; Wetzke M; von Hardenberg S
    Front Immunol; 2022; 13():1029423. PubMed ID: 36275728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Human Gain-of-Function STING Mutation Causes Immunodeficiency and Gammaherpesvirus-Induced Pulmonary Fibrosis in Mice.
    Bennion BG; Ingle H; Ai TL; Miner CA; Platt DJ; Smith AM; Baldridge MT; Miner JJ
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STING-Mediated Lung Inflammation and Beyond.
    Frémond ML; Crow YJ
    J Clin Immunol; 2021 Apr; 41(3):501-514. PubMed ID: 33532887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STING-associated vasculopathy with onset in infancy (SAVI) presenting with skin lesions.
    Latour-Álvarez I; Murcia-Clemente L; Vázquez-Pigueras I; Garramone-Ramírez JE; Clemente D; Sanz V; Torrelo A
    Pediatr Dermatol; 2024 Apr; ():. PubMed ID: 38682895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial chilblain lupus due to a gain-of-function mutation in STING.
    König N; Fiehn C; Wolf C; Schuster M; Cura Costa E; Tüngler V; Alvarez HA; Chara O; Engel K; Goldbach-Mansky R; Günther C; Lee-Kirsch MA
    Ann Rheum Dis; 2017 Feb; 76(2):468-472. PubMed ID: 27566796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Stimulator of Interferon Genes (STING) Expression by Interferon-γ in Human Keratinocytes.
    Nishikawa Y; Matsuzaki Y; Kimura K; Rokunohe A; Nakano H; Sawamura D
    Biochem Genet; 2018 Apr; 56(1-2):93-102. PubMed ID: 29143896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease.
    Chapgier A; Boisson-Dupuis S; Jouanguy E; Vogt G; Feinberg J; Prochnicka-Chalufour A; Casrouge A; Yang K; Soudais C; Fieschi C; Santos OF; Bustamante J; Picard C; de Beaucoudrey L; Emile JF; Arkwright PD; Schreiber RD; Rolinck-Werninghaus C; Rösen-Wolff A; Magdorf K; Roesler J; Casanova JL
    PLoS Genet; 2006 Aug; 2(8):e131. PubMed ID: 16934001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mutation Outside the Dimerization Domain Causing Atypical STING-Associated Vasculopathy With Onset in Infancy.
    Saldanha RG; Balka KR; Davidson S; Wainstein BK; Wong M; Macintosh R; Loo CKC; Weber MA; Kamath V; ; ; Moghaddas F; De Nardo D; Gray PE; Masters SL
    Front Immunol; 2018; 9():1535. PubMed ID: 30038614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Mimic of Childhood Granulomatosis With Polyangiitis.
    Munoz J; Rodière M; Jeremiah N; Rieux-Laucat F; Oojageer A; Rice GI; Rozenberg F; Crow YJ; Bessis D
    JAMA Dermatol; 2015 Aug; 151(8):872-7. PubMed ID: 25992765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stimulator of interferon genes-associated vasculopathy with onset in infancy: first case report in China].
    Yu ZX; Zhong LQ; Song HM; Wang CY; Wang W; Li J; Ma MS
    Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):179-185. PubMed ID: 29518827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 69.